Pharma giant AstraZeneca slides on lacklustre results
AstraZeneca shares were trading slightly lower this morning after the firm reported a 12% fall in revenues thanks to a decline in sales of a flagship cholesterol treatment.
AstraZeneca shares were trading slightly lower this morning after the firm reported a 12% fall in revenues thanks to a decline in sales of a flagship cholesterol treatment.
|
|
Shares of Lloyds Banking Group have rallied after the group beat expectations in its first-quarter results.
|
|
Architas’ Nathan Sweeney has doubled his exposure to European equities across the firm’s suite of active multi-asset funds following the French election results.
|
|
Trump’s first 100 days in office have been jam packed with outrageous tweets, ‘alternative facts,’ a failed healthcare bill and foreign policy blunders. But, what were the best and worst performing US sectors during Trump’s first 100 days?
|
|
The Share Centre’s Sheridan Admans has tipped five funds with niche styles that might offer investors a diversification opportunity.
|
|
Schroders has launched a US Equity Income Maximiser fund targeting 5% of income a year from the world’s largest stockmarket.
|
|
The fact that the Euro Stoxx 50 index recorded its largest one-day gain since July 2012 on Monday suggests the importance for investors of Emmanuel Macron’s victory in the first round of the French presidential elections can hardly be overestimated.
|
|
European shares rallied after the first round of France’s presidential election yesterday, but which funds stand to take advantage of any change in market leadership?
|
|
Top-performing emerging market fund manager Gary Greenberg is banking on a “return to normality” in developing markets.
|
|
The UK equity market pumped out 9.5% more dividends in the first quarter than the previous year as sterling’s weakness continued to magnify the payouts.
|
|
Investors’ rotation from US equities into eurozone stocks in April was the fifth largest such shift since 1999, according to the latest Bank of America Merrill Lynch fund manager survey.
|
|
The murky state of UK politics is cementing wealth manager and asset allocator aversion to domestic equity markets, as exposures continue to shrink.
|
|